Basics Rapport Therapeutics, Inc. Common Stock IPO Date: June 7, 2024 Sector: Healthcare Industry: Biotech Market Cap: $524.11M Activated in VL: True Average Daily Range Avg Daily Range: $0.80 | 4.75% Avg Daily Range (30 D): $0.58 | 3.71% Avg Daily Range (90 D): $0.53 | 4.15% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .16M Avg Daily Volume (90 D): .14M Trade Size Avg Trade Size (Sh.): 54 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 63 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $.97M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.88M Avg Closing Trade (30 D): $.51M Avg Closing Trade (90 D): $1.09M Avg Closing Volume: 182.34K     News Jun 12, 2025 @ 8:22 PM Analysts Can't Get Enough of These Little-Known Bi... Source: Marketbeat.Com Jun 2, 2025 @ 6:45 PM Rapport Therapeutics Hosts Investor and Analyst Da... Source: Rapport Therapeutics, Inc. Mar 21, 2025 @ 11:00 AM Rapport Therapeutics to Present Data at the 2025 A... Source: N/A Jan 9, 2025 @ 12:00 PM Rapport Therapeutics Announces New Phase 1 Data, F... Source: N/A Sep 5, 2024 @ 11:00 AM Rapport Therapeutics to Present at Upcoming Epilep... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.06 $-.75 $-.68 Diluted EPS $-2.06 $-.75 $-.68 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -88.31M $ -26.73M $ -24.06M Operating Income / Loss $ -101.77M $ -29.5M $ -27.11M Cost of Revenue $ $ $ Net Cash Flow $ -55.1M $ -2.54M $ .8M PE Ratio